| |
| |
|
| Insider
Information: |
Pops Richard F |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,301,687 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$38,638,136 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,301,687 |
|
|
| Total
Value |
$38,638,136 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-03-13 |
29,512 |
2005-11-23 |
0 |
Premium* |
|
|
Alkermes Plc |
ALKS |
Director and CEO, Alke... |
2024-02-08 |
1,179,675 |
2011-09-16 |
0 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
Director |
2013-05-30 |
60,000 |
|
0 |
Premium* |
|
|
Acceleron Pharma Inc |
XLRN |
Director |
2019-01-25 |
32,500 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
257 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2013-05-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
60,000 |
|
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2013-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,750 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-03-11 |
4 |
OE |
$42.76 |
$4,276 |
D/D |
100 |
29,612 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-03-11 |
4 |
AS |
$140.00 |
$14,000 |
D/D |
(100) |
29,512 |
0 |
% |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2011-11-05 |
4 |
D |
$16.12 |
$10,107 |
D/D |
(627) |
323,727 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2017-05-03 |
4 |
D |
$53.37 |
$50,808 |
D/D |
(952) |
29,512 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2016-05-16 |
4 |
D |
$45.64 |
$46,005 |
D/D |
(1,008) |
30,464 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2017-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
30,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
31,250 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
32,500 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2018-05-01 |
4 |
D |
$84.39 |
$105,741 |
D/D |
(1,253) |
43,259 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-03-08 |
4 |
OE |
$42.76 |
$72,692 |
D/D |
1,700 |
31,212 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2024-03-08 |
4 |
AS |
$140.05 |
$238,078 |
D/D |
(1,700) |
29,512 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2015-05-11 |
4 |
D |
$39.63 |
$71,374 |
D/D |
(1,801) |
16,472 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-05-27 |
4 |
D |
$16.14 |
$31,973 |
D/D |
(1,981) |
348,173 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2019-02-17 |
4 |
D |
$32.54 |
$83,725 |
D/D |
(2,573) |
700,590 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2018-02-17 |
4 |
D |
$67.26 |
$173,598 |
D/D |
(2,581) |
643,855 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-10-17 |
4 |
OE |
$7.36 |
$21,344 |
D/D |
2,900 |
351,073 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-10-17 |
4 |
AS |
$20.00 |
$58,000 |
D/D |
(2,900) |
348,173 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2012-05-17 |
4 |
D |
$16.71 |
$56,630 |
D/D |
(3,389) |
345,418 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2015-05-20 |
4 |
D |
$62.10 |
$237,657 |
D/D |
(3,827) |
531,346 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2015-05-21 |
4 |
D |
$61.80 |
$236,509 |
D/D |
(3,827) |
535,644 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2014-05-17 |
4 |
D |
$43.59 |
$166,993 |
D/D |
(3,831) |
504,209 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2014-05-20 |
4 |
D |
$43.98 |
$168,487 |
D/D |
(3,831) |
508,503 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director and CEO, Alkermes plc |
• • – |
2014-05-21 |
4 |
D |
$44.48 |
$170,403 |
D/D |
(3,831) |
512,797 |
0 |
- |
|
257 Records found
|
|
Page 1 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
